AirSculpt Technologies (AIRS) vs EUDA Health (EUDA)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
EUDA Health (EUDA) has outperformed AirSculpt Technologies (AIRS) over the past year, losing 71.8% versus a loss of 83.9%. EUDA Health is the larger company by market cap ($47.8 million vs $43.7 million), about 1.1 times the size. AirSculpt Technologies converts more of its revenue into profit, with a net margin of -7.7% versus -40.7%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | AIRS | EUDA |
|---|---|---|
| Share price | $0.5907 | $15.96 |
| Market cap | $43.67M | $47.79M |
| 1-day change | -9.72% | -7.69% |
| YTD return | -70.17% | -65.45% |
| 1-year return | -83.86% | -71.80% |
| 5-year return | -95.10% | — |
| Forward P/E | — | 9.97 |
| EPS (TTM) | $-0.12 | $-1.18 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Revenue (latest FY) | $151.82M | $6.82M |
| Revenue growth (YoY) | -15.82% | +70.04% |
| Net income (latest FY) | $-11.67M | $-2.77M |
| Gross margin | 59.37% | 43.88% |
| Operating margin | -7.61% | -36.33% |
| Net margin | -7.68% | -40.65% |
| 52-week high | $5.79 | $68.00 |
| 52-week low | $0.516 | $5.26 |
| Distance from 52-week high | -89.80% | -76.53% |
| Analyst consensus | none | none |
| Avg. price target upside | +661.81% | +244.61% |
| Average volume | 1.27M | 37.77K |
| Shares outstanding | 73.93M | 2.99M |
| Employees | 330 | 123 |
| Sector | Health Care | Health Care |
| Industry | Medical/Nursing Services | Medical/Nursing Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EUDA has outperformed AIRS by 12.1 percentage points over the past year.
- AirSculpt Technologies is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -40.7 cents for EUDA Health.
- EUDA Health grew revenue faster in its latest fiscal year (+70.04% vs -15.82%).
About AirSculpt Technologies
AIRS stock →AirSculpt Technologies, Inc., together with its subsidiaries, focuses on operating as a holding company for EBS Intermediate Parent LLC that provides body contouring procedure services in the United States and Canada. The company offers AirSculpt, a body contouring treatment that removes fat and tightens skin while sculpting targeted areas of the body in a minimally invasive procedure.
Health Care · Medical/Nursing Services · 330 employees
About EUDA Health
EUDA stock →EUDA Health Holdings Limited engages in the provision of non-invasive healthcare services primarily in Singapore, Malaysia, and China. It offers bioenergy cabin therapy packages; stem cell therapy services through third-party treatment centers; and holistic wellness consumer products and services.
Health Care · Medical/Nursing Services · 123 employees
AIRS vs EUDA FAQ
Which is bigger, AirSculpt Technologies or EUDA Health?
EUDA Health (EUDA) is larger, with a market capitalization of $47.79M compared with $43.67M for AirSculpt Technologies (AIRS).
Which stock has performed better over the past year, AIRS or EUDA?
EUDA returned -71.80% over the past 12 months, compared with -83.86% for AIRS (price return, excluding dividends). Past performance does not predict future results.
Are AirSculpt Technologies and EUDA Health in the same industry?
Yes. Both are classified in the Medical/Nursing Services industry within the Health Care sector.